+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Circulating Tumor Cell (CTC) Diagnostics - Global Market Trajectory & Analytics

  • ID: 2832326
  • Report
  • September 2020
  • Region: Global
  • 186 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • ApoCell, Inc. (US)
  • Biocep Ltd. (Israel)
  • Biocept, Inc. (US)
  • Celltraffix Inc. (US)
  • Ikonisys, Inc. (US)
  • IVDiagnostics, Inc. (US)
Global Circulating Tumor Cell (CTC) Diagnostics Market to Reach $19 Billion by 2027

Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. CTC Enrichment Methods, one of the segments analyzed in the report, is projected to record a 17.8% CAGR and reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTC Detection Methods segment is readjusted to a revised 17% CAGR for the next 7-year period.



The U. S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 16.6% CAGR

The Circulating Tumor Cell (CTC) Diagnostics market in the U. S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 16.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.4% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

CTC Analysis Segment to Record 16.3% CAGR

In the global CTC Analysis segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.3 Billion by the year 2027. We bring years of research experience to this 18th edition of our report. The 186-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • ApoCell, Inc.
  • Biocep Ltd.
  • Biocept, Inc.
  • Biofluidica Microtechnologies LLC
  • Celltraffix Inc.
  • Clearbridge Biomedics
  • Creatv Microtech, Inc.
  • Cynvenio Biosystems, Inc.
  • Fluxion Biosciences, Inc.
  • Ikonisys, Inc.
  • IVDiagnostics, Inc.
  • Janssen Diagnostics LLC
  • QIAGEN Hannover GmbH
  • Rarecells Sas
  • Screencell
  • Stemcell Technologies, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ApoCell, Inc. (US)
  • Biocep Ltd. (Israel)
  • Biocept, Inc. (US)
  • Celltraffix Inc. (US)
  • Ikonisys, Inc. (US)
  • IVDiagnostics, Inc. (US)
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Market Outlook
  • Recent Market Activity
  • Clinical Relevance of CTCs
  • CTC Detection - Real-Time 'Liquid Biopsy' Scores Over Surgical Biopsy
  • Major Challenges in CTC Diagnostics
  • Need for CTC Enrichment and Popular Methods
  • CTC Enrichment Techniques
  • Select Available CTC Detection Technologies
  • Select CTC Isolation Systems - A Brief Comparison
  • CTC Identification - Various Approaches
  • CTC Identification Approaches
  • List of mRNA Markers for RT-PCR–based Detection of CTCs by Tumor Type
  • CellSearch System™ - The First FDA Approved Automated Enrichment/Isolation Technique
  • Rising Incidence of Cancer - An Opportunity Indicator
  • Cancer Prone Sites based on Age
  • Global Competitor Market Shares
  • Circulating Tumor Cell (CTC) Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • ApoCell, Inc. (US)
  • Biocep Ltd. (Israel)
  • Biocept, Inc. (US)
  • Biofluidica Microtechnologies LLC (US)
  • Celltraffix Inc. (US)
  • Clearbridge Biomedics (Singapore)
  • Creatv Microtech, Inc. (US)
  • Cynvenio Biosystems, Inc. (US)
  • Epic Biosciences Inc. (US)
  • Fluxion Biosciences, Inc. (US)
  • Ikonisys, Inc. (US)
  • IVDiagnostics, Inc. (US)
  • Janssen Diagnostics LLC (US)
  • QIAGEN Hannover GmbH (Germany)
  • RARECELLS SAS (Italy)
  • ScreenCell (France)
  • STEMCELL Technologies, Inc. (Canada)
3. MARKET TRENDS & DRIVERS
  • Liquid Biopsy - the New Buzzword in Healthcare
  • Select Companies Active in Cancer Liquid Biopsy
  • CTCs for Personalized Cancer Treatment
  • Microfluidic Chip-based Technologies - A Promising Avenue for Cancer Diagnosis
  • CTC Microdevices Hog the Limelight
  • Increasing Research Reveal Further Complexities to CTC Composition and Behavior
  • EpCAM Glycoprotein - Insufficient for CTC Detection
  • New Isolation Techniques Show Promise in Detecting EpCAM-Negative CTCs
  • Physical Property-based Enrichment Technologies Lose Fizz
  • Evidence in Favor CTC Heterogeneity Gains Strength
  • CTC Clusters Raise Research Interest
  • Detection of EMTs Gains Precedence in the Backdrop of Recent Research Findings
  • Limitations of CTC Technology for Point-of-Care Testing
  • CTC Technologies Offer an Edge over Imaging Tests for Breast Cancer Prognosis
  • Limited Biomarkers Utilized In CTC Diagnostics - A Threat to Market Growth?
  • Select Research Findings in Recent Years
  • Microfluidic Device with Micro-Hall Sensors Detect CTCs with Higher Sensitivity and Specificity
  • NBiomics Makes its Contribution to CTC Diagnosis
  • Researchers at University of Michigan Develop Revolutionary Capture CTCs Method
  • Dean Flow Fractionation to Overcome Limitations Associated with Conventional Biomarker Analysis
  • Gold Nanoparticles Help in the Detection of CTCs
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Circulating Tumor Cell (CTC) Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Circulating Tumor Cell (CTC) Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Circulating Tumor Cell (CTC) Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: CTC Enrichment Methods (Technology) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: CTC Enrichment Methods (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: CTC Enrichment Methods (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: CTC Detection Methods (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: CTC Detection Methods (Technology) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: CTC Detection Methods (Technology) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: CTC Analysis (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: CTC Analysis (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: CTC Analysis (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Cancer Stem Cell Research (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
  • TABLE 14: Cancer Stem Cell Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 15: Cancer Stem Cell Research (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: EMT Biomarkers Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 17: EMT Biomarkers Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 18: EMT Biomarkers Development (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Tumorgenesis Research (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Tumorgenesis Research (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Tumorgenesis Research (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Circulating Tumor Cell (CTC) Diagnostics Market Share (in %) by Company: 2018 & 2025
  • Market Analytics
  • TABLE 25: Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million in the United States by Technology: 2020-2027
  • TABLE 26: United States Circulating Tumor Cell (CTC) Diagnostics Market Retrospective Analysis in US$ Million by Technology: 2012-2019
  • TABLE 27: United States Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
  • TABLE 28: United States Circulating Tumor Cell (CTC) Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 29: Circulating Tumor Cell (CTC) Diagnostics Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
  • TABLE 30: Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
  • TABLE 31: Circulating Tumor Cell (CTC) Diagnostics Market Analysis in Canada in US$ Million by Technology: 2020-2027
  • TABLE 32: Circulating Tumor Cell (CTC) Diagnostics Market in Canada: Historic Review in US$ Million by Technology for the Period 2012-2019
  • TABLE 33: Canadian Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
  • TABLE 34: Canadian Circulating Tumor Cell (CTC) Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 35: Circulating Tumor Cell (CTC) Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 36: Canadian Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
  • TABLE 37: Japanese Medium & Long-Term Outlook for Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Technology: 2020-2027
  • TABLE 38: Circulating Tumor Cell (CTC) Diagnostics Market in Japan in US$ Million by Technology: 2012-2019
  • TABLE 39: Japanese Circulating Tumor Cell (CTC) Diagnostics Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027
  • TABLE 40: Japanese Demand Estimates and Forecasts for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 41: Japanese Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Application: 2012-2019
  • TABLE 42: Circulating Tumor Cell (CTC) Diagnostics Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
CHINA
  • TABLE 43: Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027
  • TABLE 44: Chinese Circulating Tumor Cell (CTC) Diagnostics Retrospective Market Scenario in US$ Million by Technology: 2012-2019
  • TABLE 45: Circulating Tumor Cell (CTC) Diagnostics Market in China: Percentage Share Analysis by Technology for 2012, 2020, and 2027
  • TABLE 46: Chinese Demand for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 47: Circulating Tumor Cell (CTC) Diagnostics Market Review in China in US$ Million by Application: 2012-2019
  • TABLE 48: Chinese Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European Circulating Tumor Cell (CTC) Diagnostics Market: Competitor Market Share Scenario (in %) for 2018 & 2025
  • Market Analytics
  • TABLE 49: European Circulating Tumor Cell (CTC) Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 50: Circulating Tumor Cell (CTC) Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 51: European Circulating Tumor Cell (CTC) Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 52: European Circulating Tumor Cell (CTC) Diagnostics Market Assessment in US$ Million by Technology: 2020-2027
  • TABLE 53: European Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Technology: 2012-2019
  • TABLE 54: Circulating Tumor Cell (CTC) Diagnostics Market in Europe: Percentage Breakdown of Salesby Technology for 2012, 2020, and 2027
  • TABLE 55: European Circulating Tumor Cell (CTC) Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 56: Circulating Tumor Cell (CTC) Diagnostics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 57: European Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 58: French Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027
  • TABLE 59: French Circulating Tumor Cell (CTC) Diagnostics Historic Market Analysis in US$ Million by Technology: 2012-2019
  • TABLE 60: French Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
  • TABLE 61: Circulating Tumor Cell (CTC) Diagnostics Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
  • TABLE 62: French Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 63: French Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
  • TABLE 64: German Circulating Tumor Cell (CTC) Diagnostics Latent Demand Forecasts in US$ Million by Technology: 2020-2027
  • TABLE 65: Circulating Tumor Cell (CTC) Diagnostics Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012-2019
  • TABLE 66: German Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
  • TABLE 67: Circulating Tumor Cell (CTC) Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 68: German Circulating Tumor Cell (CTC) Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 69: Circulating Tumor Cell (CTC) Diagnostics Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
ITALY
  • TABLE 70: Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027
  • TABLE 71: Italian Circulating Tumor Cell (CTC) Diagnostics Retrospective Market Scenario in US$ Million by Technology: 2012-2019
  • TABLE 72: Circulating Tumor Cell (CTC) Diagnostics Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and 2027
  • TABLE 73: Italian Demand for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 74: Circulating Tumor Cell (CTC) Diagnostics Market Review in Italy in US$ Million by Application: 2012-2019
  • TABLE 75: Italian Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
  • TABLE 76: United Kingdom Medium & Long-Term Outlook for Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Technology: 2020-2027
  • TABLE 77: Circulating Tumor Cell (CTC) Diagnostics Market in the United Kingdom in US$ Million by Technology: 2012-2019
  • TABLE 78: United Kingdom Circulating Tumor Cell (CTC) Diagnostics Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027
  • TABLE 79: United Kingdom Demand Estimates and Forecasts for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 80: United Kingdom Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Application: 2012-2019
  • TABLE 81: Circulating Tumor Cell (CTC) Diagnostics Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 82: Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Market Assessment in US$ Million by Technology: 2020-2027
  • TABLE 83: Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Technology: 2012-2019
  • TABLE 84: Circulating Tumor Cell (CTC) Diagnostics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027
  • TABLE 85: Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 86: Circulating Tumor Cell (CTC) Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 87: Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 88: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027
  • TABLE 89: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Historic Market Analysis in US$ Million by Technology: 2012-2019
  • TABLE 90: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS 2027
  • TABLE 91: Circulating Tumor Cell (CTC) Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
  • TABLE 92: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 93: Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027
REST OF WORLD
  • TABLE 94: Circulating Tumor Cell (CTC) Diagnostics Market Analysis in Rest of World in US$ Million by Technology: 2020-2027
  • TABLE 95: Circulating Tumor Cell (CTC) Diagnostics Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2012-2019
  • TABLE 96: Rest of World Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
  • TABLE 97: Rest of World Circulating Tumor Cell (CTC) Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 98: Circulating Tumor Cell (CTC) Diagnostics Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 99: Rest of World Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 48
Note: Product cover images may vary from those shown
  • ApoCell, Inc. (US)
  • Biocep Ltd. (Israel)
  • Biocept, Inc. (US)
  • Biofluidica Microtechnologies LLC (US)
  • Celltraffix Inc. (US)
  • Clearbridge Biomedics (Singapore)
  • Creatv Microtech, Inc. (US)
  • Cynvenio Biosystems, Inc. (US)
  • Epic Biosciences Inc. (US)
  • Fluxion Biosciences, Inc. (US)
  • Ikonisys, Inc. (US)
  • IVDiagnostics, Inc. (US)
  • Janssen Diagnostics LLC (US)
  • QIAGEN Hannover GmbH (Germany)
  • RARECELLS SAS (Italy)
  • ScreenCell (France)
  • STEMCELL Technologies, Inc. (Canada)
Note: Product cover images may vary from those shown
Adroll
adroll